UPDATE : Monday, December 9, 2019
상단여백
Daewoong's reaffirms drug-marketing power with Daiichi Sankyo's NOAC treatment
Daewoong proved its sales power once again as it solidified its top positio...
by Lee Han-soo  |  2019-10-01 16:43
라인
Drugmakers’ illegal rebates down, support for doctors up
Pharmaceutical companies’ offering of illicit rebates to physicians have de...
by Kwak Sung-sun  |  2019-10-01 13:49
라인
Crystal Genomics confirms efficacy of epigenetics-based pulmonary fibrosis treatment
Crystal Genomics said it has presented the results of the preclinical study...
by Lee Han-soo  |  2019-10-01 11:21
라인
‘Merck Korea unilaterally lays off employees’
Merck Biopharma Korea has been embroiled in a labor dispute.Merck Korea bra...
by Kim Yun-mi  |  2019-10-01 11:09
라인
Allergan to compensate breast implant recipients for damage
Allergan agreed to provide full compensation for the medical expenses of pa...
by Lee Hye-seon  |  2019-09-30 15:33
라인
Ranitidine recall taking heavy toll on pharmaceuticals
Pharmaceutical companies are expected to suffer massive losses due to the r...
by Jeong Sae-im  |  2019-09-30 15:16
라인
Sale of Novartis’ conjunctivitis drug Pataday banned for 3 months
The Ministry of Food and Drug Safety has suspended the sale of Novartis Kor...
by Lee Hye-seon  |  2019-09-30 11:25
라인
Investor trust in bio-industrialists sank due to latter’s unethical acts
The biotech industry is losing trust from investors as some executives at t...
by Lee Han-soo  |  2019-09-27 15:11
라인
Genexine sets up joint firm in Thailand
Genexine said that it has established KinGen Biotech in Thailand, a joint v...
by Lee Han-soo  |  2019-09-26 17:00
라인
[Analysis] Successive failures throw Korean bioindustry's drug-developing ability into question
The recent failures by Korean biotech companies to reach meaningful results...
by Lee Han-soo  |  2019-09-26 15:39
라인
Pfizer’s leukemia therapy Besponsa to get insurance benefit
The government said it would grant insurance benefit to Pfizer’s leukemia t...
by Kim Yun-mi  |  2019-09-26 11:26
라인
'Xtandi emerges as convenient treatment option for prostate cancer patients'
Astellas Korea is strengthening its position in the local prostate cancer m...
by Lee Han-soo  |  2019-09-25 17:39
라인
Huons, Lipac Oncology to co-develop bladder cancer treatment
Huons said that it has signed an exclusive licensing agreement for developi...
by Lee Han-soo  |  2019-09-25 11:18
라인
AstraZeneca releases detailed results of P3 trial of SGLT2 inhibitor
AstraZeneca announced detailed results of the landmark phase 3 DAPA-HF tria...
by Lee Han-soo  |  2019-09-24 18:08
라인
Qurient enrolls patients for trials of atopy treatment
Qurient said Tuesday that it has completed patient enrollment for phase 2b ...
by Lee Han-soo  |  2019-09-24 17:00
라인
Hanmi’s US partner to unveil results of anticancer drug study
Hanmi Pharmaceutical said that Athenex, its U.S. partner, plans to present ...
by Lee Han-soo  |  2019-09-24 17:00
라인
Why using end-to-end services should be part of a drug product strategy
Specialized services offered by end-to-end service providers are essential ...
by Lee Han-soo  |  2019-09-24 16:54
라인
Helixmith's fails to end P3 trials of diabetic peripheral neuropathy treatment
Helixmith said that it has failed to make conclusions due to data contamina...
by Lee Han-soo  |  2019-09-24 16:38
라인
Hwail, SupexBNP wins patent for neutropenia treatment in US
Hwail Pharmaceutical and SupexBNP said that they have registered a patent f...
by Lee Han-soo  |  2019-09-23 22:34
라인
Drug firms uncertain about pricing of quadrivalent flu vaccines
As the 2019-2020 flu season approaches, pharmaceutical firms are engaging i...
by Jeong Sae-im  |  2019-09-23 14:52
여백
여백
여백
Back to Top